Related Experiment Videos
Angioimmunoblastic lymphadenopathy: a T-cell deficiency.
Cancer
|August 1, 1978
Summary
This case study details a patient with angioimmunoblastic lymphadenopathy, showing impaired cell-mediated immunity with low T-cells and high B-cells. Treatment with corticosteroids improved symptoms but led to staphylococcal septicemia.
Area of Science:
- Immunology
- Hematology
- Oncology
Background:
- Angioimmunoblastic lymphadenopathy (AILD) is a rare T-cell lymphoma.
- AILD often presents with systemic symptoms and immune dysregulation.
Observation:
- A 49-year-old male patient diagnosed with AILD experienced a severe clinical course.
- Corticosteroid treatment led to significant clinical improvement.
- The patient developed staphylococcal septicemia during treatment.
Findings:
- Pre-treatment immunological studies revealed impaired cell-mediated immunity.
- Quantification showed decreased T-lymphocytes and increased B-lymphocytes.
- Skin window tests indicated reduced lymphocyte migration, consistent with immunosuppression.
Implications:
- This case highlights the complex immune dysregulation in AILD.
- Understanding the pathogenetic mechanisms of AILD is crucial for effective treatment.
- Further research is needed to identify the unknown cause of this entity.